The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Deletion of a mycobacterial divisome factor collapses single-cell phenotypic heterogeneity
Open accessAbstract
Microorganisms are often studied as populations but the behaviour of single, individual cells can have important consequences. For example, tuberculosis, caused by the bacterial pathogen Mycobacterium tuberculosis, requires months of antibiotic therapy even though the bulk of the bacterial population dies rapidly. Shorter courses lead to high rates of relapse because subpopulations of bacilli can survive despite being genetically identical to those that are easily killed. In fact, mycobacteria create variability each time a cell divides, producing daughter cells with different sizes and growth rates. The mechanism(s) that underlie this high-frequency variation and how variability relates to survival of the population are unknown. Here we show that mycobacteria actively create heterogeneity. Using a fluorescent reporter and a fluorescence-activated cell sorting (FACS)-based transposon screen, we find that deletion of lamA, a gene of previously unknown function, decreases heterogeneity in the population by decreasing asymmetric polar growth. LamA has no known homologues in other organisms, but is highly conserved across mycobacterial species. We find that LamA is a member of the mycobacterial division complex (the 'divisome'). It inhibits growth at nascent new poles, creating asymmetry in polar growth. The kinetics of killing individual cells that lack lamA are more uniform and more rapid with rifampicin and drugs that target the cell wall. Our results show that mycobacteria encode a non-conserved protein that controls the pattern of cell growth, resulting in a population that is both heterogeneous and better able to survive antibiotic pressure.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Strikingly, asymmetric division is an actively regulated process, not the result of random septal placement; a mutant of M. smegmatis lacking lamA elongates and divides symmetrically (124).”
From Mycobacterium smegmatis: The Vanguard of Mycobacterial Research (2023) · cites this paper as [124]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“LamA localizes to the septum, where it interacts with the PBP PonA1 and inhibits growth at the developing new pole.”
From The mycobacterial cell envelope — a moving target (2020) · cites this paper as [40]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Fiji: an open-source platform for biological-image analysis
Schindelin, J., Arganda-Carreras, I., Frise, E., Kaynig, V., Longair, M., Pietzsch, T., Preibisch, S., Rueden, C., Saalfeld, S., Schmid, B., et al. (2012) · Nature Methods · doi:10.1038/nmeth.2019 · Cited by 66,890
Bacterial Persistence as a Phenotypic Switch
Balaban, N. Q., Merrin, J., Chait, R., Kowalik, L., & Leibler, S. (2004) · Science · doi:10.1126/science.1099390 · Cited by 2,952
Distinguishing between resistance, tolerance and persistence to antibiotic treatment
Brauner, A., Fridman, O., Gefen, O., & Balaban, N. Q. (2016) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2016.34 · Cited by 1,612
Cell-Size Control and Homeostasis in Bacteria
Taheri-Araghi, S., Bradde, S., Sauls, J. T., Hill, N. S., Levin, P. A., Paulsson, J., Vergassola, M., & Jun, S. (2014) · Current Biology · doi:10.1016/j.cub.2014.12.009 · Cited by 715
Recombineering in Mycobacterium tuberculosis
van Kessel, J. C., & Hatfull, G. F. (2006) · Nature Methods · doi:10.1038/nmeth996 · Cited by 586
Dynamic Persistence of Antibiotic-Stressed Mycobacteria
Wakamoto, Y., Dhar, N., Chait, R., Schneider, K., Signorino‐Gelo, F., Leibler, S., & McKinney, J. D. (2013) · Science · doi:10.1126/science.1229858 · Cited by 536
A Constant Size Extension Drives Bacterial Cell Size Homeostasis
Campos, M., Surovtsev, I. V., Kato, S., Paintdakhi, A., Beltran, B. G., Ebmeier, S., & Jacobs, C. (2014) · Cell · doi:10.1016/j.cell.2014.11.022 · Cited by 475
Asymmetry and Aging of Mycobacterial Cells Lead to Variable Growth and Antibiotic Susceptibility
Aldridge, B. B., Fernandez-Suarez, M., Heller, D., Ambravaneswaran, V., Irimia, D., Toner, M., & Fortune, S. M. (2012) · Science · doi:10.1126/science.1216166 · Cited by 454
In vivo transposition of mariner -based elements in enteric bacteria and mycobacteria
Rubin, E. J., Akerley, B. J., Novik, V., Lampe, D. J., Husson, R. N., & Mekalanos, J. J. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.4.1645 · Cited by 358
Self-citationRole of individual drugs in the chemotherapy of tuberculosis.
Mitchison, D. A. (2000) · PubMed · Cited by 314
Cited by
Sorted by citations
Anti-tuberculosis treatment strategies and drug development: challenges and priorities
Dartois, V. A., & Rubin, E. J. (2022) · Nature Reviews Microbiology · doi:10.1038/s41579-022-00731-y · Cited by 490
Self-citationImmunometabolism at the interface between macrophages and pathogens
Russell, D. G., Huang, L., & VanderVen, B. C. (2019) · Nature reviews. Immunology · doi:10.1038/s41577-019-0124-9 · Cited by 470
The mycobacterial cell envelope — a moving target
Dulberger, C. L., Rubin, E. J., & Boutte, C. C. (2020) · Nature Reviews Microbiology · doi:10.1038/s41579-019-0273-7 · Cited by 365
Self-citationA decade of advances in transposon-insertion sequencing
Cain, A. K., Barquist, L., Goodman, A. L., Paulsen, I. T., Parkhill, J., & van Opijnen, T. (2020) · Nature Reviews Genetics · doi:10.1038/s41576-020-0244-x · Cited by 397
The causes of evolvability and their evolution
Payne, J. L., & Wagner, A. (2018) · Nature Reviews Genetics · doi:10.1038/s41576-018-0069-z · Cited by 392
Evolutionary causes and consequences of bacterial antibiotic persistence
Bakkeren, E., Diard, M., & Hardt, W. (2020) · Nature Reviews Microbiology · doi:10.1038/s41579-020-0378-z · Cited by 232
Drug resistant tuberculosis: Implications for transmission, diagnosis, and disease management
Liebenberg, D., Gordhan, B. G., & Kana, B. D. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.943545 · Cited by 220
Biology of antimicrobial resistance and approaches to combat it
Schrader, S. M., Vaubourgeix, J., & Nathan, C. (2020) · Science Translational Medicine · doi:10.1126/scitranslmed.aaz6992 · Cited by 174
Mycobacterium smegmatis: The Vanguard of Mycobacterial Research
Sparks, I. L., Derbyshire, K. M., Jacobs, W. R., & Morita, Y. S. (2023) · Journal of Bacteriology · doi:10.1128/jb.00337-22 · Cited by 149
A black phosphorus based synergistic antibacterial platform against drug resistant bacteria
Ouyang, J., Liu, R., Chen, W., Liu, Z., Xu, Q., Zeng, K., Deng, L., Shen, L., & Liu, Y. (2018) · Journal of Materials Chemistry B · doi:10.1039/c8tb01669k · Cited by 132
Maturing Mycobacterium smegmatis peptidoglycan requires non-canonical crosslinks to maintain shape
Baranowski, C., Welsh, M. A., Sham, L.-T., Eskandarian, H. A., Lim, H. C., Kieser, K. J., Wagner, J. C., McKinney, J. D., Fantner, G. E., Ioerger, T. R., et al. (2018) · eLife · doi:10.7554/elife.37516 · Cited by 132
Self-citationPeptidoglycan precursor synthesis along the sidewall of pole-growing mycobacteria
García-Heredia, A., Pohane, A. A., Melzer, E. S., Carr, C. R., Fiolek, T. J., Rundell, S. R., Lim, H. C., Wagner, J. C., Morita, Y. S., Swarts, B. M., et al. (2018) · eLife · doi:10.7554/elife.37243 · Cited by 115
Integrated Proteome Analysis Device for Fast Single-Cell Protein Profiling
Shao, X., Wang, X., Guan, S. U., Lin, H., Yan, G., Gao, M., Deng, C., & Zhang, X. (2018) · Analytical Chemistry · doi:10.1021/acs.analchem.8b03692 · Cited by 116
MmpL Proteins in Physiology and Pathogenesis of M. tuberculosis
Melly, G. C., & Purdy, G. E. (2019) · Microorganisms · doi:10.3390/microorganisms7030070 · Cited by 112
Mycobacterium tuberculosis: Bacterial Fitness within the Host Macrophage
Huang, L., Nazarova, E. V., & Russell, D. G. (2019) · Microbiology Spectrum · doi:10.1128/microbiolspec.bai-0001-2019 · Cited by 120
Targeting redox heterogeneity to counteract drug tolerance in replicating Mycobacterium tuberculosis
Mishra, R., Kohli, S., Malhotra, N., Bandyopadhyay, P., Mehta, M., Munshi, M., Adiga, V., Ahuja, V. K., Shandil, R. K., Rajmani, R. S., et al. (2019) · Science Translational Medicine · doi:10.1126/scitranslmed.aaw6635 · Cited by 113
Zhu, J., Wang, B.-W., Pan, M., Zeng, Y., Rego, H., & Javid, B. (2018) · Nature Communications · doi:10.1038/s41467-018-06667-3 · Cited by 106
de Wet, T. J., Winkler, K. R., Mhlanga, M., Mizrahi, V., & Warner, D. F. (2020) · eLife · doi:10.7554/elife.60083 · Cited by 79
Targeting the Proteostasis Network for Mycobacterial Drug Discovery
Lupoli, T. J., Vaubourgeix, J., Burns-Huang, K. E., & Gold, B. S. (2018) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.7b00231 · Cited by 91
Sakatos, A., Babunovic, G. H., Chase, M. R., Dills, A. H., Leszyk, J., Rosebrock, T. R., Bryson, B. D., & Fortune, S. M. (2018) · Science Advances · doi:10.1126/sciadv.aao1478 · Cited by 83
Archaeal cells share common size control with bacteria despite noisier growth and division
Eun, Y.-J., Ho, P.-Y., Kim, M., LaRussa, S., Robert, L., Renner, L. D., Schmid, A., Garner, E. C., & Amir, A. (2017) · Nature Microbiology · doi:10.1038/s41564-017-0082-6 · Cited by 86
Phenotypic heterogeneity in persisters: a novel ‘hunker’ theory of persistence
Urbaniec, J., Xu, Y., Hu, Y., Hingley‐Wilson, S., & McFadden, J. (2021) · FEMS Microbiology Reviews · doi:10.1093/femsre/fuab042 · Cited by 83
Low-Fidelity Assembly of Influenza A Virus Promotes Escape from Host Cells
Vahey, M. D., & Fletcher, D. A. (2018) · Cell · doi:10.1016/j.cell.2018.10.056 · Cited by 79
Antimicrobial resistance in enteric bacteria: current state and next-generation solutions
Wallace, M. J., Fishbein, S. R. S., & Dantas, G. A. (2020) · Gut Microbes · doi:10.1080/19490976.2020.1799654 · Cited by 82
Salmonella Populations inside Host Cells
Castanheira, S. M., & del Portillo, F. G. (2017) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2017.00432 · Cited by 82
Rifamycin antibiotics and the mechanisms of their failure
Adams, R. A., Leon, G., Miller, N. M., Reyes, S. P., Thantrong, C. H., Thokkadam, A., Lemma, A. S., Sivaloganathan, D. M., Wan, X., & Brynildsen, M. P. (2021) · The Journal of Antibiotics · doi:10.1038/s41429-021-00462-x · Cited by 81
Transporters Involved in the Biogenesis and Functionalization of the Mycobacterial Cell Envelope
Jackson, M., Stevens, C. M., Zhang, L., Zgurskaya, H. I., & Niederweis, M. (2020) · Chemical Reviews · doi:10.1021/acs.chemrev.0c00869 · Cited by 69
Logsdon, M. M., Ho, P.-Y., Papavinasasundaram, K., Richardson, K., Cokol, M., Sassetti, C. M., Amir, A., & Aldridge, B. B. (2017) · Current Biology · doi:10.1016/j.cub.2017.09.046 · Cited by 69
Tolerance and Persistence to Drugs: A Main Challenge in the Fight Against Mycobacterium tuberculosis
Boldrin, F., Provvedi, R., Mazzabò, L. C., Segafreddo, G., & Manganelli, R. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.01924 · Cited by 68
Cell size control and gene expression homeostasis in single-cells
Vargas-García, C. A., Ghusinga, K. R., & Singh, A. (2018) · Current Opinion in Systems Biology · doi:10.1016/j.coisb.2018.01.002 · Cited by 63
Types and functions of heterogeneity in mycobacteria
Chung, E. S., Johnson, W. C., & Aldridge, B. B. (2022) · Nature Reviews Microbiology · doi:10.1038/s41579-022-00721-0 · Cited by 61
Wang, C., Wang, C., Wu, Y., Gao, J., Han, Y., Chu, Y., Qiang, L., Qiu, J., Gao, Y., Wang, Y., et al. (2022) · Advanced Healthcare Materials · doi:10.1002/adhm.202102800 · Cited by 61
Melzer, E. S., Sein, C. E., Chambers, J. J., & Siegrist, M. S. (2018) · Cytoskeleton · doi:10.1002/cm.21490 · Cited by 54
Botella, H., Yang, G., Ouerfelli, O., Ehrt, S., Nathan, C., & Vaubourgeix, J. (2017) · mBio · doi:10.1128/mbio.01183-17 · Cited by 54
Zeng, J., Platig, J., Cheng, T., Ahmed, S., Skaf, Y., Potluri, L., Schwartz, D., Steen, H., Moody, D. B., & Husson, R. N. (2020) · PLoS Pathogens · doi:10.1371/journal.ppat.1008452 · Cited by 58
Transposon Insertion Sequencing, a Global Measure of Gene Function
van Opijnen, T., & Levin, H. L. (2020) · Annual Review of Genetics · doi:10.1146/annurev-genet-112618-043838 · Cited by 58
Logsdon, M. M., & Aldridge, B. B. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.00514 · Cited by 54
The evolving biology of Mycobacterium tuberculosis drug resistance
Jones, R. M., Adams, K. N., Eldesouky, H. E., & Sherman, D. R. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.1027394 · Cited by 54
The relevance of persisters in tuberculosis drug discovery
Mandal, S., Njikan, S., Kumar, A., Early, J. V., & Parish, T. (2019) · Microbiology · doi:10.1099/mic.0.000760 · Cited by 52
CinA mediates multidrug tolerance in Mycobacterium tuberculosis
Kreutzfeldt, K. M., Jansen, R. S., Hartman, T. E., Gouzy, A., Wang, R., Krieger, I. V., Zimmerman, M. D., Gengenbacher, M., Sarathy, J. P., Xie, M., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-29832-1 · Cited by 47
A biphasic growth model for cell pole elongation in mycobacteria
Hannebelle, M. T. M., Ven, J. X. Y., Toniolo, C., Eskandarian, H. A., Vuaridel‐Thurre, G., McKinney, J. D., & Fantner, G. E. (2020) · Nature Communications · doi:10.1038/s41467-019-14088-z · Cited by 47
Vijay, S., Vinh, D. N., Hai, H. T., Ha, V. T. N., Dung, V. T. M., Dinh, T. D., Nhung, H. N., Tram, T. T. B., Aldridge, B. B., Hanh, N. T., et al. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.02296 · Cited by 42
Division-Based, Growth Rate Diversity in Bacteria
Nana, G. G., Ripoll, C., Cabin‐Flaman, A., Gibouin, D., Delaune, A., Jannière, L., Grancher, G., Chagny, G., Loutelier‐Bourhis, C., Lentzen, E., et al. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.00849 · Cited by 46
Hockenberry, A. M., Micali, G., Takács, G., Weng, J., Hardt, W., & Ackermann, M. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2103027118 · Cited by 46
The Biological and Clinical Aspects of a Latent Tuberculosis Infection
Khabibullina, N. F., Kutuzova, D. M., Burmistrova, I. A., & Lyadova, I. V. (2022) · Tropical Medicine and Infectious Disease · doi:10.3390/tropicalmed7030048 · Cited by 50
Fluorescent Mycobacterium tuberculosis reporters: illuminating host–pathogen interactions
MacGilvary, N. J., & Tan, S. (2018) · Pathogens and Disease · doi:10.1093/femspd/fty017 · Cited by 44
Understanding the contribution of metabolism to Mycobacterium tuberculosis drug tolerance
Samuels, A. N., Wang, E. R., Harrison, G. A., Valenta, J. C., & Stallings, C. L. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.958555 · Cited by 43
Block, A. M., Namugenyi, S. B., Palani, N. P., Brokaw, A. M., Zhang, L., Beckman, K. B., & Tischler, A. D. (2023) · mSystems · doi:10.1128/msystems.00699-22 · Cited by 40
Chaudhuri, S., Li, L., Zimmerman, M. D., Chen, Y., Chen, Y., Toosky, M., Gardner, M., Pan, M., Li, Y., Kawaji, Q., et al. (2018) · eLife · doi:10.7554/elife.36782 · Cited by 39
Self-citationCambré, A., & Aertsen, A. (2020) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00008-20 · Cited by 41
Baranowski, C., Rego, E. H., & Rubin, E. J. (2019) · Microbiology Spectrum · doi:10.1128/microbiolspec.gpp3-0008-2018 · Cited by 36
Self-citationChung, E. S., Kar, P., Kamkaew, M., Amir, A., & Aldridge, B. B. (2024) · Nature Microbiology · doi:10.1038/s41564-024-01846-z · Cited by 35
Spatial control of cell envelope biosynthesis in mycobacteria
Puffal, J., García‐Heredia, A., Rahlwes, K. C., Siegrist, M. S., & Morita, Y. S. (2018) · Pathogens and Disease · doi:10.1093/femspd/fty027 · Cited by 30
Parbhoo, T., Mouton, J., & Sampson, S. L. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.956607 · Cited by 39
Molecular Mechanisms of MmpL3 Function and Inhibition
Williams, J. T., & Abramovitch, R. B. (2023) · Microbial Drug Resistance · doi:10.1089/mdr.2021.0424 · Cited by 31
Dhar, R., Missarova, A., Lehner, B., & Carey, L. B. (2019) · eLife · doi:10.7554/elife.38904 · Cited by 32
Mishra, R., Yadav, V., Guha, M., & Singh, A. (2020) · Trends in Microbiology · doi:10.1016/j.tim.2020.10.013 · Cited by 28
Tissue compartmentalization enables Salmonella persistence during chemotherapy
Li, J., Claudi, B., Fanous, J., Chicherova, N., Cianfanelli, F. R., Campbell, R. A. A., & Bumann, D. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2113951118 · Cited by 29
Heterogeneity of Salmonella-host interactions in infected host tissues
Bumann, D., & Cunrath, O. (2017) · Current Opinion in Microbiology · doi:10.1016/j.mib.2017.09.008 · Cited by 29
Clinically relevant mutations in mycobacterial LepA cause rifampicin-specific phenotypic resistance
Wang, B.-W., Zhu, J., & Javid, B. (2020) · Scientific Reports · doi:10.1038/s41598-020-65308-2 · Cited by 28
Dusny, C., Lohse, M. J., Reemtsma, T., Schmid, A., & Lechtenfeld, O. J. (2019) · Analytical Chemistry · doi:10.1021/acs.analchem.9b00978 · Cited by 28
Mycobacterium smegmatis HtrA Blocks the Toxic Activity of a Putative Cell Wall Amidase
Wu, K. J., Boutte, C. C., Ioerger, T. R., & Rubin, E. J. (2019) · Cell Reports · doi:10.1016/j.celrep.2018.12.063 · Cited by 28
Self-citationNon-genetic variability in microbial populations: survival strategy or nuisance?
Levien, E., Min, J., Kondev, J., & Amir, A. (2021) · Reports on Progress in Physics · doi:10.1088/1361-6633/ac2c92 · Cited by 30
Gupta, K. R., Gwin, C. M., Rahlwes, K. C., Biegas, K. J., Wang, C., Park, J., Liu, J., Swarts, B. M., Morita, Y. S., & Rego, E. H. (2022) · eLife · doi:10.7554/elife.80395 · Cited by 28
Self-citationDelineating FtsQ-mediated regulation of cell division in Mycobacterium tuberculosis
Jain, P., Malakar, B., Khan, M. Z., Lochab, S., Singh, A. K., & Nandicoori, V. K. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.003628 · Cited by 26
Cell Surface Biosynthesis and Remodeling Pathways in Mycobacteria Reveal New Drug Targets
Shaku, M. T., Ealand, C. S., & Kana, B. D. (2020) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.603382 · Cited by 26
Microfluidics as a Novel Technique for Tuberculosis: From Diagnostics to Drug Discovery
Molloy, A., Harrison, J., McGrath, J. S., Owen, Z., Smith, C. A., Liu, X., Li, X., & Cox, J. A. G. (2021) · Microorganisms · doi:10.3390/microorganisms9112330 · Cited by 24
Stevanovic, M., Boukéké-Lesplulier, T., Hupe, L., Hasty, J., Bittihn, P., & Schultz, D. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.740259 · Cited by 23
Reframing antimicrobial resistance as a continuous spectrum of manifestations
Schrader, S. M., Botella, H., & Vaubourgeix, J. (2023) · Current Opinion in Microbiology · doi:10.1016/j.mib.2022.102259 · Cited by 28
Mycobacterium tuberculosis Reporter Strains as Tools for Drug Discovery and Development
Abramovitch, R. B. (2018) · IUBMB Life · doi:10.1002/iub.1862 · Cited by 26
de Wet, T. J., Gobe, I., Mhlanga, M. M., & Warner, D. F. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/358275 · Cited by 28
Lipoarabinomannan mediates localized cell wall integrity during division in mycobacteria
Sparks, I. L., Kado, T., Prithviraj, M., Nijjer, J., Yan, J. Q., & Morita, Y. S. (2024) · Nature Communications · doi:10.1038/s41467-024-46565-5 · Cited by 24
McGowen, K., Funck, T., Wang, X., Zinga, S., Wolf, I. D., Akusobi, C., Denkinger, C. M., Rubin, E. J., & Sullivan, M. R. (2025) · PLoS Pathogens · doi:10.1371/journal.ppat.1013027 · Cited by 23
Self-citationHira, J., Uddin, M. J., Haugland, M. M., & Lentz, C. S. (2020) · Molecules · doi:10.3390/molecules25214949 · Cited by 23
Persistent Mycobacterium tuberculosis infection in mice requires PerM for successful cell division
Wang, R., Kreutzfeldt, K. M., Botella, H., Vaubourgeix, J., Schnappinger, D., & Ehrt, S. (2019) · eLife · doi:10.7554/elife.49570 · Cited by 21
For the Greater (Bacterial) Good: Heterogeneous Expression of Energetically Costly Virulence Factors
Davis, K. M. (2020) · Infection and Immunity · doi:10.1128/iai.00911-19 · Cited by 22
Melzer, E. S., Kado, T., García‐Heredia, A., Gupta, K. R., Méniche, X., Morita, Y. S., Sassetti, C. M., Rego, E. H., & Siegrist, M. S. (2022) · Journal of Bacteriology · doi:10.1128/jb.00540-21 · Cited by 23
Self-citationMistretta, M., Cimino, M., Campagne, P., Volant, S., Kornobis, É., Hebert, O., Rochais, C., Dallemagne, P., Lecoutey, C., Tisnerat, C., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-48269-2 · Cited by 22
Cell-Cycle-Associated Expression Patterns Predict Gene Function in Mycobacteria
Bandekar, A. C., Subedi, S., Ioerger, T. R., & Sassetti, C. M. (2020) · Current Biology · doi:10.1016/j.cub.2020.07.070 · Cited by 20
Cell wall synthesizing complexes in Mycobacteriales
Meyer, F. M., & Bramkamp, M. (2024) · Current Opinion in Microbiology · doi:10.1016/j.mib.2024.102478 · Cited by 19
Savijoki, K., Myllymäki, H., Luukinen, H., Paulamäki, L., Vanha-aho, L.-M., Svorjova, A., Miettinen, I., Fallarero, A., Ihalainen, T. O., Yli‐Kauhaluoma, J. T., et al. (2021) · mSystems · doi:10.1128/msystems.00500-21 · Cited by 20
Models versus pathogens: how conserved is the FtsZ in bacteria?
Battaje, R. R., Piyush, R., Pratap, V., & Panda, D. (2023) · Bioscience Reports · doi:10.1042/bsr20221664 · Cited by 21
Parbhoo, T., Sampson, S. L., & Mouton, J. (2020) · Cytometry Part A · doi:10.1002/cyto.a.24030 · Cited by 22
Are all antibiotic persisters created equal?
Shultis, M. W., Mulholland, C. V., & Berney, M. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.933458 · Cited by 19
Pióro, M., Małecki, T., Portas, M., Magierowska, I., Trojanowski, D., Sherratt, D. J., Zakrzewska‐Czerwińska, J., Ginda, K., & Jakimowicz, D. (2018) · Molecular Microbiology · doi:10.1111/mmi.14149 · Cited by 19
Keasey, S. L., Suh, M., Das, S., Blancett, C. D., Zeng, X., Andrésson, Þ., Sun, M., & Ulrich, R. G. (2019) · Molecular & Cellular Proteomics · doi:10.1074/mcp.ra118.000739 · Cited by 19
Non-Darwinian Molecular Biology
Palazzo, A. F., & Kejiou, N. S. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.831068 · Cited by 16
Jaisinghani, N., Previti, M. L., Andrade, J., Askenazi, M., Ueberheide, B. M., & Seeliger, J. C. (2023) · Cell chemical biology · doi:10.1016/j.chembiol.2023.10.013 · Cited by 17
Martínez, S. R., Durantini, A. M., Becerra, M. C., & Cosa, G. (2020) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.0c00317 · Cited by 17
GlnR Activation Induces Peroxide Resistance in Mycobacterial Biofilms
Yang, Y., Richards, J. P., Gundrum, J., & Ojha, A. K. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.01428 · Cited by 17
Phenotypic Heterogeneity in Pathogens
Sherry, J., & Rego, E. H. (2024) · Annual Review of Genetics · doi:10.1146/annurev-genet-111523-102459 · Cited by 22
Self-citationTools to develop antibiotic combinations that target drug tolerance in Mycobacterium tuberculosis
Greenstein, T., & Aldridge, B. B. (2023) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.1085946 · Cited by 17
Polar protein Wag31 both activates and inhibits cell wall metabolism at the poles and septum
Arejan, N. H., Ensinck, D., Diacovich, L., Patel, P., Quintanilla, S. Y., Saleh, A. E., Gramajo, H., & Boutte, C. C. (2022) · bioRxiv · doi:10.3389/fmicb.2022.1085918 · Cited by 12
Arejan, N. H., Czapski, D. R., Buonomo, J. A., & Boutte, C. C. (2024) · Journal of Bacteriology · doi:10.1128/jb.00204-24 · Cited by 14
Intercellular communication and social behaviors in mycobacteria
Boopathi, S., Ramasamy, S., Haridevamuthu, B., Murugan, R., Veerabadhran, M., Jia, A., & Arockiaraj, J. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.943278 · Cited by 16
The Mycomembrane Differentially and Heterogeneously Restricts Antibiotic Permeation
Lepori, I., Jackson, K., Liu, Z., Chordia, M. D., Wong, M., Rivera, S. L., Roncetti, M., Poliseno, L., Freundlich, J. S., Pires, M. M., et al. (2025) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.4c01062 · Cited by 12
Estimating treatment prolongation for persistent infections
Martinecz, A., & Wiesch, P. A. Z. (2018) · Pathogens and Disease · doi:10.1093/femspd/fty065 · Cited by 15
Bioenergetic reprogramming of macrophages reduces drug tolerance in Mycobacterium tuberculosis
Yadav, V., Sahoo, S., Malhotra, N., Mishra, R., Sreedharan, S., Rajmani, R. S., Shanmugam, S. K., Shandil, R. K., Narayanan, S., Thacker, V. V., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-64407-w · Cited by 16
Persistence of Mycobacterium tuberculosis in response to infection burden and host-induced stressors
Parbhoo, T., Schurz, H., Mouton, J., & Sampson, S. L. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.981827 · Cited by 14
Fernández-García, G., Valdés-Chiara, P., Villazán-Gamonal, P., Alonso-Fernández, S., & Manteca, Á. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252011298 · Cited by 14
Metadata
- Authors
- Rego, E. H., Audette, R. E., & Rubin, E. J.
- Affiliations
- Harvard University (US)
- Corresponding author
- Rego, E. Hesper
- Rubin, Eric J.
- Venue
- Nature
- Published
- 2017-05-31
- Volume
- 546
- Issue
- 7656
- Pages
- 153-157
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC5567998
- OpenAlex
- W2617852583
- Cited by
- 186
- References
- 22
- Citations by year
- 2026: 14 · 2025: 15 · 2024: 18 · 2023: 16 · 2022: 23 · 2021: 16 · 2020: 25 · 2019: 22 · 2018: 30 · 2017: 7
- FWCI
- 17.68
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- National Institute of Allergy and Infectious Diseases (U19AI107774, F32AI104287)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Tuberculosis Research and Epidemiology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Bacterial Genetics and Biotechnology
- Health Sciences › Medicine › Epidemiology › Mycobacterium research and diagnosis
- Keywords
- lamas, divisome, Mycobacterium tuberculosis, cell wall synthesis inhibition, cell division, phenotypic heterogeneity, antibiotic tolerance, rifampicin, tuberculosis drug targets, single-cell heterogeneity
- MeSH terms
- Anti-Bacterial Agents, Bacterial Proteins, Cell Division, Cell Wall, DNA Mutational Analysis, Flow Cytometry, Fluoresceins, Phenotype, Rifampin, Reproducibility of Results, Cell Polarity, Gene Deletion, Mycobacterium smegmatis, Microbial Viability, Single-Cell Analysis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review